Receptors for calcium antagonists

Am J Cardiol. 1988 Oct 5;62(11):3G-6G. doi: 10.1016/0002-9149(88)90024-0.

Abstract

Calcium antagonists have been divided into 3 different subclasses represented by nifedipine, verapamil and diltiazem. These drugs have different pharmacologic effects and are not interchangeable. Previous studies suggested that all calcium antagonists bind to a 170 kd polypeptide (now called the alpha 2 subunit of the voltage-dependent calcium channel). The apparent molecular weight of this polypeptide characteristically decreased from 170 to 140 kd upon disulfide reduction as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Recent studies demonstrated that calcium antagonists bind to a previously unrecognized 165 kd polypeptide (alpha 1 subunit) that does not change its electrophoretic mobility on disulfide reduction. Because of their similar molecular weights, the 2 polypeptides may overlap each other on polyacrylamide gels. The primary structure of both polypeptides clearly shows, however, that they are different from each other and only the alpha 1 subunit has the features expected of an ion channel.

Publication types

  • Review

MeSH terms

  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels / drug effects*
  • Diltiazem / pharmacology
  • Humans
  • Nifedipine / pharmacology
  • Receptors, Nicotinic / metabolism*
  • Verapamil / pharmacology

Substances

  • Calcium Channel Blockers
  • Calcium Channels
  • Receptors, Nicotinic
  • Verapamil
  • Diltiazem
  • Nifedipine